Bridgebio Pharma Inc (BBIO)

Operating Expenses

$1.21B

TTM · Period ending: · USD

BBIO logo

BBIO Operating Expenses

Latest reported$1.21B
BBIO Operating Expenses ($43.86M → $1.21B)
High-resolution chart · PNG

BBIO operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
1,042,892,000
810,997,000
614,227,000
586,416,000
643,234,000
482,731,000
304,300,000
183,660,000
43,858,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.